Navigation Links
Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Date:9/7/2007

most commonly diagnosed cancer in men, accounting for 30 percent of all male cancers, and prostate cancer is second only to lung cancer as a leading cause of male cancer deaths. Currently, there is no cure for locally advanced or metastatic prostate cancer.

"We are delighted that bavituximab shrank resistant human prostate tumors in this study, an important new sign of its potential anti-cancer efficacy," said Steven W. King, president and CEO of Peregrine. "Preclinically, we have now shown that adding bavituximab equivalent antibodies to combination regimens significantly enhances the anti-tumor activity of cancer chemotherapy, of hormone deprivation therapy and of radiation therapy in prostate, breast, lung, brain and pancreatic cancers. The breadth of these potential applications supports many options for future clinical studies."

Bavituximab is a monoclonal antibody that binds to a phospholipid called phosphatidylserine that is normally located inside normal cells, but which becomes exposed on the outside of the cells that line the blood vessels of tumors, creating a specific target for anti-cancer treatments. Bavituximab is believed to help mobilize the body's immune system to destroy the blood vessels needed for tumor growth and spread. In a Phase Ib trial in advanced cancer patients to assess its safety in combination with common chemotherapy agents, bavituximab plus chemotherapy appeared to have a safety profile consistent with chemotherapy alone and showed positive signs of clinical activity, achieving objective response or disease stabilization in 50% of the evaluable patients. A protocol for a Phase II trial of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer (NSCLC) is currently undergoing regulatory review in India. Bavituximab is also in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

This study, entitled "Vascular Targeting Antib
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
2. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
3. Peregrine Pharmaceuticals Highlights Significant Advances in the Companys Clinical and Preclinical Cancer Programs Presented This Week at the AACR Annual Meeting
4. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
5. Data Presented at AACR Meeting Show Peregrines Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
6. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
7. NIEHS Researchers Identify Enzyme Critical in DNA Replication
8. Stanford Researchers Find Brain Pathway of Depression in Rats
9. Researchers Discover Method for Identifying How Cancer Evades the Immune System
10. Researchers Discover Gene For Rare Skin Disorder
11. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)...  The non-surgical Stretta® procedure employing ... is effective in control of gastroesophageal reflux disease ... medication 10 years post-procedure, according to an independent, ... Disease Week (DDW) meeting May 18-21, 2013 in ... "The sustained improvement in GERD-HRQL scores and ...
(Date:5/18/2013)... , May 18, 2013 Although colonoscopy ... are considered the most sensitive method for detecting colorectal ... in preventing cancer cases 3 . EndoChoice ® ... Fuse™ system significantly improves the accuracy of this procedure ... colonoscopists. EndoChoice will be discussing these clinical trial results ...
(Date:5/18/2013)... May 18, 2013 The Open Paradigm ... Occupy Psychiatry , and leading organizations ... announces a social media campaign showcasing video testimonials ... model, which focuses on pathology and illness rather ... the American Psychiatric Association,s (APA) rollout of its ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3
... 28, 2011   For the second year in a row the ... the Starkey Hearing Foundation deliver the gift of hearing ... York City area. The Starkey Hearing Foundation New York Yankees Hearing ... visit by New York Yankees Pitcher CC Sabathia, Manager Joe ...
... ROCKLAND, Mass., June 28, 2011 In strong collaboration ... and more compact version of the LokomatPro that offers ... gait therapy device in 2001, the LokomatPro has established ... function in patients with neurological diseases and injuries resulting ...
Cached Medicine Technology:New York Yankees Help Starkey Hearing Foundation Deliver the Gift of Hearing to New York Area Children and Adults in Need 2New York Yankees Help Starkey Hearing Foundation Deliver the Gift of Hearing to New York Area Children and Adults in Need 3Hocoma Launches New Version of its Established Gait Training Device LokomatPro 2
(Date:5/19/2013)... Park City, Utah (PRWEB) May 19, 2013 ... new information on small business health insurance ... alternatives to traditional employer sponsored health benefits, is ... contribution and health reimbursement arrangements . ... businesses, start-ups, and the self-employed intrinsically know the ...
(Date:5/19/2013)... 19, 2013 The report “Feed Additives ... & Forecasts up to 2017” published by MarketsandMarkets, defines ... analysis and forecasting of the global volume and revenue ... driving and restraining factors for the global market with ... challenges. The market is segmented and revenue is forecasted ...
(Date:5/19/2013)... Keith Chertok now provides gum disease patients with a new ... chance of a healthier smile. Laser gum surgery ... removes diseased gum tissue in patients, but it also stimulates ... implants. , LANAP uses a laser to successfully treat ... the healthy tissue as well as encourage new bone growth. ...
(Date:5/19/2013)... St. Petersburg, FL (PRWEB) May 19, 2013 ... Sublime Beauty ®, who is reintroducing a great practice ... today. "Skin Brushing, also known as dry body brushing, ... says Kathy Heshelow, founder of Sublime Beauty®. "We love ... that functioning of our largest organ, the skin, is ...
(Date:5/19/2013)... Vedra Beach, Florida (PRWEB) May 19, 2013 ... value and market access, is pleased to unveil a ... trade show environment that provides a powerful array of ... to partners in the US and abroad. , HE-Xpo ... and will offer attendees the look and feel of ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
... HealthDay Reporter , TUESDAY, Sept. 14 (HealthDay News) ... quick, accurate decisions in all aspects of life, new findings ... in the journal Current Biology theorize that action ... evidence drawn from their senses in decision-making, a skill known ...
... Researchers at Children,s Hospital Boston have developed a new ... Carolina at Chapel Hill to engage health care practitioners ... and real-time pharmacovigilance. The application, "MedWatcher," allows users to ... alerts from the Food and Drug Administration (FDA), as ...
... 14, 2010 Neuralstem, Inc. (NYSE Amex: CUR) ... in rat brains affected by stroke and differentiated ... improvement in some motor skill and strength measurements. ... Neural Stem Cells To Reverse Motor Deficits in ...
... analysis, researchers at Oregon Health & Science University and ... accurately predict a young person,s age simply by studying ... several clinical applications, including assessment and diagnosis, is published ... . For several years, OHSU researcher Damien ...
... class of drugs is highly effective in reducing common bone ... today that these same drugs when used long term ... the thigh bone. In the most comprehensive scientific ... 310 cases of "atypical femur fractures," and found that 94 ...
... 13, 2010) USGI Medical, Inc., the Incisionless ... confirm durability of the company,s Expandable Tissue Anchors ... variety of incisionless gastrointestinal (GI) procedures, including use ... to repair dilated tissue after gastric bypass. ...
Cached Medicine News:Health News:Action-Packed Video Games May Be Good for You After All 2Health News:Action-Packed Video Games May Be Good for You After All 3Health News:New iPhone app, 'MedWatcher,' to support real-time drug safety surveillance 2Health News:Neuralstem stem cells survive and differentiate into neurons in rats with stroke 2Health News:OHSU researchers able to determine brain maturity through analyzing MRI scans 2Health News:New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients 2Health News:New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients 3Health News:USGI medical tissue anchors show durability beyond 1 year 2
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
... ADVIA 2400 Chemistry System pushes your ... reliability and stability that keep you ... probe cycle time maximizes tube speed ... the systems efficient automation-readiness, gives you ...
... convenience make the RD/Hitachi 902 the ... workload laboratory. Compact, sample selective clinical ... 26 tests on board (including 3 ... tests per hour respectively up to ...
Modular Pre-Analytics is an integral component of the new modular systems platform which combines pre-analytics, clinical chemistry and immunochemistry....
Medicine Products: